ロード中...
Detection of BRAFV600E in Liquid Biopsy from Patients with Papillary Thyroid Cancer Is Associated with Tumor Aggressiveness and Response to Therapy
The detection of rare mutational targets in plasma (liquid biopsy) has emerged as a promising tool for the assessment of patients with cancer. We determined the presence of cell-free DNA containing the BRAFV600E mutations (cfBRAFV600E) in plasma samples from 57 patients with papillary thyroid cancer...
保存先:
| 出版年: | J Clin Med |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7464493/ https://ncbi.nlm.nih.gov/pubmed/32748840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9082481 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|